LON:AGL - ANGLE Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
GBX 56 -1.00 (-1.75 %)
(As of 07/22/2018 04:49 AM ET)
Previous CloseGBX 56
Today's RangeGBX 54 - GBX 57.50
52-Week RangeGBX 32.27 - GBX 80
Volume103,157 shs
Average Volume106,228 shs
Market Capitalization£39.71 million
P/E RatioN/A
Dividend YieldN/A
ANGLE logoANGLE plc, a medical diagnostic company, provides cancer diagnostics and foetal health products. Its lead product is Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLE plc was founded in 2004 and is based in Guildford, the United Kingdom.

Receive AGL News and Ratings via Email

Sign-up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry Medical Laboratories & Research


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-1,824.47%
Return on Equity-69.67%
Return on Assets-62.25%


Outstanding Shares112,510,000
Market Cap£39.71

ANGLE (LON:AGL) Frequently Asked Questions

What is ANGLE's stock symbol?

ANGLE trades on the London Stock Exchange (LON) under the ticker symbol "AGL."

What price target have analysts set for AGL?

0 brokers have issued 1-year target prices for ANGLE's stock. Their predictions range from GBX 110 to GBX 110. On average, they anticipate ANGLE's share price to reach GBX 110 in the next year. This suggests a possible upside of 96.4% from the stock's current price. View Analyst Ratings for ANGLE.

What is the consensus analysts' recommendation for ANGLE?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ANGLE in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of ANGLE's key competitors?

Who are ANGLE's key executives?

ANGLE's management team includes the folowing people:
  • Mr. Andrew David William Newland Meng, ACA, Founder, CEO & Exec. Director (Age 56)
  • Mr. Ian Francis Griffiths, CFO, Fin. Director, Company Sec. & Exec. Director (Age 53)
  • Mr. Martin Cooke, Director of Operations & Regulatory Affairs (Age 49)
  • Mr. Paul Smith, VP & Chief Exec. Officer of ANGLE Biosciences Inc
  • Mrs. Peggy Robinson, NA VP (Age 60)

Has ANGLE been receiving favorable news coverage?

News coverage about AGL stock has trended somewhat positive on Sunday, according to Accern. The research firm ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ANGLE earned a media sentiment score of 0.24 on Accern's scale. They also gave press coverage about the company an impact score of 46.36 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of ANGLE?

Shares of AGL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is ANGLE's stock price today?

One share of AGL stock can currently be purchased for approximately GBX 56.

How big of a company is ANGLE?

ANGLE has a market capitalization of £39.71 million.

How can I contact ANGLE?

ANGLE's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company can be reached via phone at +44-1483-685830.

MarketBeat Community Rating for ANGLE (LON AGL)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  135 (Vote Underperform)
Total Votes:  204
MarketBeat's community ratings are surveys of what our community members think about ANGLE and other stocks. Vote "Outperform" if you believe AGL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AGL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.